Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/CA/Fresno

Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fresno, CA

Q: How much do paid clinical trials in Fresno pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Q: Do I need to be sick to join a clinical trial in Fresno?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Q: Are clinical trials in Fresno safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Q: How often do new paid studies open in Fresno?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fresno.

Q: Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fresno typically complete one or two studies per year.

Studies commonly pay $75 to $4,500 per completed study

166 clinical trials are currently recruiting participants within 30 miles of Fresno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

166studies recruiting

4+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Fresno right now

Top 25 of 166 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Multiple Myeloma Phase 3 Interventional 944 participants sought

Community Regional Medical Center — Fresno, California (2.7 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT05020236)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06124157)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought

Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought

University of California — Fresno, California (2.7 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought

Urology Associates of Central California — Fresno, California (2.7 mi) · Sponsor: Pacific Edge Limited

See eligibility & contact on ClinicalTrials.gov (NCT06394869)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought

Community Cancer Institute (CCI) — Clovis, California (5.8 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06793215)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma Phase 3 Interventional 440 participants sought

Research Site — Madera, California (19.2 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06307665)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought

Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06580314)

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Cognitive Impairment, Mild, Dementia Phase 4 Interventional 20,000 participants sought

Fresno VA Medical Center — Fresno, California (2.7 mi) · Sponsor: Duke University

See eligibility & contact on ClinicalTrials.gov (NCT04262206)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 50 participants sought

Neurocrine Clinical Site — Fresno, California (2.7 mi) · Sponsor: Neurocrine Biosciences

See eligibility & contact on ClinicalTrials.gov (NCT07105111)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: PedAL BCU, LLC

See eligibility & contact on ClinicalTrials.gov (NCT04726241)

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Benign Prostatic Hyperplasia (BPH) N/A Interventional 256 participants sought

Urology Associates of Central California — Fresno, California (2.7 mi) · Sponsor: Olympus Corporation of the Americas

See eligibility & contact on ClinicalTrials.gov (NCT04757116)

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

Urinary Tract Infections Phase 2 Interventional 318 participants sought

Research Site 138 — Fresno, California (2.7 mi) · Sponsor: Locus Biosciences

See eligibility & contact on ClinicalTrials.gov (NCT05488340)

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor Phase 3 Interventional 1,656 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT06401330)

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Cardiac Arrest, Cardiopulmonary Arrest N/A Observational 7,000 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Hospital of Philadelphia

See eligibility & contact on ClinicalTrials.gov (NCT02708134)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Diabetic Foot Ulcer N/A Interventional 450 participants sought

VA Central California Healthcare — Fresno, California (2.7 mi) · Sponsor: Piomic Medical

See eligibility & contact on ClinicalTrials.gov (NCT05758545)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought

Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: Wake Forest University Health Sciences

See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 84 participants sought

Community Cancer Institute — Clovis, California (5.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT03739814)

OssDsign® Spine Registry Study ("Propel")

Degenerative Disc Disease, Spinal Stenosis N/A Observational 450 participants sought

Community Health Partners Neuroscience — Fresno, California (2.7 mi) · Sponsor: OssDsign

See eligibility & contact on ClinicalTrials.gov (NCT05329129)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought

Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Actively enrolling

Studies you may be able to join near Fresno

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Fresno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Fresno Clinical Research Center

★ 5.0

7102 N Fresno St Ste 101, Fresno, CA 93720

(559) 712-6199

Website

"Very kind and very professional"

— Vivian, 5★

Beacon Clinical Resarch Institute

1111 E Warner Ave, Fresno, CA 93720

(410) 718-2908

Website

Valley Research

★ 5.0

550 E Herndon Ave #101, Fresno, CA 93720

(559) 261-0992

Website

"I just completed a diabetic study with Valley Research. I worked with Lucas Anderson and Rowena Liwag. The knowledge that was shared was immense, we…"

— Betty Benoit, 5★

Clinical Research Center

Fresno, CA 93720

(559) 450-7790

Website

Clinical trials in Fresno: what's recruiting

The Fresno area currently has 166 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fresno, the most active research areas are:

Cancer & Oncology15 studies
Lungs & Breathing2 studies
Heart & Vascular2 studies
Liver & Kidney2 studies
Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Fresno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fresno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fresno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fresno pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Fresno?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Fresno safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How often do new paid studies open in Fresno?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fresno.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fresno typically complete one or two studies per year.

Paid clinical trials near Fresno

Other metros within reach

Visalia, CA2 Merced, CA29 Modesto, CA99 Bakersfield, CA68 Salinas, CA44 Stockton, CA100 Santa Maria, CA93 San Jose, CA1,132

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fresno Bladder Issues Due To Spinal Cord Injury in Fresno All conditions

More of CA

Long Beach3,348 Torrance3,239 Fullerton3,230 Anaheim3,164 Garden Grove3,162 Pomona3,123 Glendale2,948 Los Angeles2,936 Huntington Beach2,847 Santa Clarita2,389 Hayward2,266 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts